Learn More
Human Matriptase/ST14 Catalytic Domain Antibody, R&D Systems™

Description
Specifications
Specifications
| Antigen | Matriptase/ST14 |
| Applications | Western Blot, Flow Cytometry, CyTOF |
| Classification | Polyclonal |
| Concentration | LYOPH |
| Conjugate | Unconjugated |
| Dilution | Western Blot 0.1 ug/mL, Intracellular Staining by Flow Cytometry 2.5 ug/10^6 cells, CyTOF-ready |
| Gene Accession No. | Q9Y5Y6 |
| Gene Alias | EC 3.4.21, Epithin, HAI, Matriptase, Membrane-type serine protease 1, MTSP1, MT-SP1EC 3.4.21.109, prostamin, PRSS14, Serine protease 14, Serine protease TADG-15, SNC19, SNC19MTSP1, ST14, suppression of tumorigenicity 14 (colon carcinoma), suppression of tumorigenicity 14 (colon carcinoma, matriptase, epithin), suppressor of tumorigenicity 14 protein, TADG15, TADG-15, TMPRSS14, tumor associated differentially expressed gene 15 protein, Tumor-associated differentially-expressed gene 15 protein |
| Gene Symbols | ST14 |
| Host Species | Sheep |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.